Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  Check Out View Cart

Country Report

Rx/Reimbursement adult incontinence in

Rx/Reimbursement Adult Incontinence in Norway

14 pages, Mar 2018

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Reimbursement through the Blue Receipt system

While hospital costs, including for adult incontinence, are covered for the whole population by the government, the reimbursement scheme in Norway is limited to the Blue Receipt system. Only those diagnosed with incontinence can receive a Blue Receipt from their medical practitioner.

Prescription less strict and product choice left to the patient

Recognising that medical practitioners are not always in a position to decide if a patient diagnosed with incontinence needed pants diapers, open diapers or pads, the Norwegian Parliament has loosened the requirements regarding the prescription details when it comes to adult incontinence. Patients are now able to try and choose the product that better fits their needs and their lifestyle.

Light incontinence mainly excluded from the reimbursement scheme

As the reimbursement scheme is only valid through the Blue Receipt system, and Blue Receipts are delivered upon a medically diagnosed condition, light incontinence is largely excluded from the scheme. The stigma surrounding addressing this question with a doctor, and a lack of full awareness of the causes of incontinence, reduces the number of occasions when light incontinence is medically diagnosed, and a Blue Receipt given.

Files are delivered directly into your account within a few minutes of purchase.

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

SAMPLES

FAQS ABOUT SAMPLES

DELIVERY

Files are delivered directly into your account within a few minutes of purchase.

OVERVIEW

Discover the latest market trends and uncover sources of future market growth for the Rx/Reimbursement adult incontinence industry in Norway with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Rx/Reimbursement adult incontinence industry in Norway, our research will save you time and money while empowering you to make informed, profitable decisions.

The Rx/Reimbursement adult incontinence in Norway market research report includes:

Analysis of key supply-side and demand trends
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Rx/Reimbursement adult incontinence in Norway?
What are the major brands in Norway?
What are the most important channels for Rx/Reimbursement adult incontinence products?
How do light incontinence products perform compared to moderate/heavy incontinence products?

WHY BUY THIS REPORT?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our

Tissue and Hygiene market research database

Want to find out more about this report?

Request more information

Rx/Reimbursement Adult Incontinence in Norway - Category analysis

HEADLINES

PROSPECTS

Reimbursement through the Blue Receipt system

Prescription less strict and product choice left to the patient

Light incontinence mainly excluded from the reimbursement scheme

CATEGORY DATA

Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2012-2017
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2012-2017
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2017-2022
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2017-2022

Tissue and Hygiene in Norway - Industry Overview

EXECUTIVE SUMMARY

Innovation, innovation, innovation

Private label is gaining ground, but traditional brands are resisting the pressure

Essity AS and Metsä Tissue AS dominate the market

Discounters are not yet challenged by internet retailing

Habits are hard to break but innovation can surprise the Norwegian consumer

MARKET INDICATORS

Table 5 Birth Rates 2012-2017
Table 6 Infant Population 2012-2017
Table 7 Female Population by Age 2012-2017
Table 8 Total Population by Age 2012-2017
Table 9 Households 2012-2017
Table 10 Forecast Infant Population 2017-2022
Table 11 Forecast Female Population by Age 2017-2022
Table 12 Forecast Total Population by Age 2017-2022
Table 13 Forecast Households 2017-2022

MARKET DATA

Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2012-2017
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2012-2017
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2013-2017
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2014-2017
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2012-2017
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2012-2017
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2017
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2017-2022
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2017-2022

Megatrends

Country Report

Rx/Reimbursement Adult Incontinence in Norway

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Reimbursement through the Blue Receipt system

Prescription less strict and product choice left to the patient

Light incontinence mainly excluded from the reimbursement scheme

Overview

Why buy this report?

SAMPLES

DELIVERY

OVERVIEW

WHY BUY THIS REPORT?

Want to find out more about this report?

Table of Contents

Rx/Reimbursement Adult Incontinence in Norway - Category analysis

HEADLINES

PROSPECTS

Reimbursement through the Blue Receipt system

Prescription less strict and product choice left to the patient

Light incontinence mainly excluded from the reimbursement scheme

CATEGORY DATA

Tissue and Hygiene in Norway - Industry Overview

EXECUTIVE SUMMARY

Innovation, innovation, innovation

Private label is gaining ground, but traditional brands are resisting the pressure

Essity AS and Metsä Tissue AS dominate the market

Discounters are not yet challenged by internet retailing

Habits are hard to break but innovation can surprise the Norwegian consumer

MARKET INDICATORS

MARKET DATA

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Recently Viewed

Complete Catalogue

Country Reports